Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 181 AL 195

The good, the bad, and the ugly: A three-circuit model of Parkinson's tremor

Helmich RC, van den Berg KRE.

Rev Neurol (Paris). 2026 Nov;182(9):806-810. doi: 10.1016/j.neurol.2026.09.003. Epub 2026 Oct 1.

In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson's disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation

Caroppo P, Aprea V, Villa C, Dellarole IL, Romeo A, Rossi G, Ciullini A, Burato A, Prioni S, Grisoli M, Legname G, Simmini G, Luppino A, Mazzetti S, Moda F, Devigili G.

Mol Neurodegener. 2026 Oct 1;21(1):61. doi: 10.1186/s13024-026-01000-9.

Outcomes of a Simplified Two-Catheter Approach for Catheter Ablation of SVT in Pediatric Patients

Cervantes JD, Mansour AA, Cortez D.

Pacing Clin Electrophysiol. 2026 Oct 2. doi: 10.1111/pace.70458. Online ahead of print.

AI-driven transcriptomics for neurodegenerative disease research: A systematic review

Tripathi A, Yadav AK, Kumar N.

Comput Biol Chem. 2026 Sep 29;126(Pt 1):109448. doi: 10.1016/j.compbiolchem.2026.109448. Online ahead of print.

Dopaminergic transmissive dormancy as a protective state against cellular stress

Zuurbier KR, Solano Fonseca R, Snowden J, Douglas PM.

Genes Dev. 2026 Oct 2. doi: 10.1101/gad.353957.126. Online ahead of print.

Beyond granulomatous amoebic encephalitis: changing epidemiology and an expanding spectrum of non-flagellated amoebic CNS infection in India

Gupta N, Reghukumar A, Kumar TP.

Infection. 2026 Oct 3. doi: 10.1007/s15010-026-02986-6. Online ahead of print.

Precision cognitive neurorehabilitation: dose, adaptivity, digital therapeutics and implementation

Sander FW, Sallard É, Silva M, Schneider L, Diserens K, Graf C, Serino A, Sokolov AA.

Expert Rev Neurother. 2026 Nov;26(11):1123-1140. doi: 10.1080/14737175.2026.2723909. Epub 2026 Oct 4.

From danger to resolution: targeting purinergic signaling in CNS diseases

Degryse C, Gupta K, Buée L, Burnouf T, Blum D, Chou ML.

Med Chem Res. 2026 Oct;35(10):2007-2027. doi: 10.1007/s00044-026-03583-w. Epub 2026 Oct 5.

Frontal aperiodic activity and sensorimotor theta clustering are differentially modulated by tDCS during proprioceptive training in Parkinson's disease: An EEG study

Heydarpour H, Ashtiani MN, Bahrpeyma F, Tafakhori A.

Neuroscience. 2026 Nov 28;617:154-161. doi: 10.1016/j.neuroscience.2026.10.005. Epub 2026 Oct 5.

Targeting the temporal architecture of movement in Parkinson's disease

Pauletti C, Suppa A.

Clin Neurophysiol. 2026 Oct 3:2112422. doi: 10.1016/j.clinph.2026.2112422. Online ahead of print.

The Role of Mast Cells and Their Potential as a Therapeutic Target For Neuroinflammation

Scuderi SA, Basilotta R, Cucinotta L, Ardizzone A, Esposito E.

J Inflamm Res. 2026 Sep 29;19:540890. doi: 10.2147/JIR.S540890. eCollection 2026.

Does genetic testing remain relevant in advanced Parkinson's disease?

Westenberger A, Endaya NJ, Brüggemann N.

J Neural Transm (Vienna). 2026 Oct 6. doi: 10.1007/s00702-026-03295-w. Online ahead of print.

[Potential role of CHI3L1 in ischemic stroke - a neuroinflammatory or neuroprotective factor?]

Klachacz A, Malik A.

Postepy Biochem. 2026 Oct 6;72(3):201-210. doi: 10.18388/wht2rw10.

Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases

Tian Q, Tong Y, Yu F, Hu X.

CNS Neurosci Ther. 2026 Oct;32(10):e71118. doi: 10.1002/cns.71118.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias